Structure-Activity Relationships of Radioiodinated Benzoimidazopyridine Derivatives for Detection of Tau Pathology
- PMID: 29795763
- PMCID: PMC5949832
- DOI: 10.1021/acsmedchemlett.8b00092
Structure-Activity Relationships of Radioiodinated Benzoimidazopyridine Derivatives for Detection of Tau Pathology
Abstract
It is generally accepted that neurofibrillary tangles consisting of tau proteins are involved in the pathogenesis of Alzheimer's disease (AD). For selective detection of tau pathology, we synthesized and evaluated radioiodinated benzoimidazopyridine (BIP) derivatives with an alkylamino group as tau imaging probes. In vitro selectivity to tau aggregates and in vivo pharmacokinetics of BIP derivatives varied markedly, being strongly dependent on the alkylamino group. In in vitro autoradiography with AD brain sections, the BIP derivative with a dimethylamino group (BIP-NMe2) showed the highest selectivity to tau aggregates. Regarding the biodistribution using normal mice, the BIP derivative with an ethylamino group (BIP-NHEt) showed the highest uptake (6.04% ID/g at 2 min postinjection) into and rapid washout (0.12% ID/g at 60 min postinjection) from the brain. These results suggest that the introduction of an optimal alkylamino group into the BIP scaffold may lead to the development of more potential tau imaging probes.
Conflict of interest statement
The authors declare no competing financial interest.
Figures






Similar articles
-
Structure-Activity Relationships of Radioiodinated 6,5,6-Tricyclic Compounds for the Development of Tau Imaging Probes.ACS Med Chem Lett. 2020 Jan 9;11(2):120-126. doi: 10.1021/acsmedchemlett.9b00456. eCollection 2020 Feb 13. ACS Med Chem Lett. 2020. PMID: 32071677 Free PMC article.
-
Highly Selective Tau-SPECT Imaging Probes for Detection of Neurofibrillary Tangles in Alzheimer's Disease.Sci Rep. 2016 Sep 30;6:34197. doi: 10.1038/srep34197. Sci Rep. 2016. PMID: 27687137 Free PMC article.
-
18F-labeled benzimidazopyridine derivatives for PET imaging of tau pathology in Alzheimer's disease.Bioorg Med Chem. 2019 Aug 15;27(16):3587-3594. doi: 10.1016/j.bmc.2019.06.039. Epub 2019 Jun 26. Bioorg Med Chem. 2019. PMID: 31285098
-
[Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].Yakugaku Zasshi. 2017;137(11):1361-1365. doi: 10.1248/yakushi.17-00156. Yakugaku Zasshi. 2017. PMID: 29093372 Review. Japanese.
-
Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.Gerontology. 1997;43 Suppl 1:16-23. doi: 10.1159/000213882. Gerontology. 1997. PMID: 9187935 Review.
Cited by
-
The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET.Biomolecules. 2023 Feb 3;13(2):290. doi: 10.3390/biom13020290. Biomolecules. 2023. PMID: 36830659 Free PMC article. Review.
-
Characterization and Optimization of Benzimidazopyrimidine and Pyridoimidazopyridine Derivatives as Tau-SPECT Probes.ACS Med Chem Lett. 2021 Apr 26;12(5):805-811. doi: 10.1021/acsmedchemlett.1c00071. eCollection 2021 May 13. ACS Med Chem Lett. 2021. PMID: 34055229 Free PMC article.
-
Strategies of positron emission tomography (PET) tracer development for imaging of tau and α-synuclein in neurodegenerative disorders.RSC Med Chem. 2024 Nov 20. doi: 10.1039/d4md00576g. Online ahead of print. RSC Med Chem. 2024. PMID: 39678127 Free PMC article. Review.
-
Structure-Activity and Brain Kinetics Relationships of 18F-Labeled Benzimidazopyridine Derivatives as Tau PET Tracers.ACS Med Chem Lett. 2021 Jan 11;12(2):262-266. doi: 10.1021/acsmedchemlett.0c00641. eCollection 2021 Feb 11. ACS Med Chem Lett. 2021. PMID: 33603973 Free PMC article.
-
Structure-Activity Relationships of Radioiodinated 6,5,6-Tricyclic Compounds for the Development of Tau Imaging Probes.ACS Med Chem Lett. 2020 Jan 9;11(2):120-126. doi: 10.1021/acsmedchemlett.9b00456. eCollection 2020 Feb 13. ACS Med Chem Lett. 2020. PMID: 32071677 Free PMC article.
References
-
- Rowe C. C.; Ng S.; Ackermann U.; Gong S. J.; Pike K.; Savage G.; Cowie T. F.; Dickinson K. L.; Maruff P.; Darby D.; Smith C.; Woodward M.; Merory J.; Tochon-Danguy H.; O’Keefe G.; Klunk W. E.; Mathis C. A.; Price J. C.; Masters C. L.; Villemagne V. L. Imaging β-amyloid burden in aging and dementia. Neurology 2007, 68, 1718–1725. 10.1212/01.wnl.0000261919.22630.ea. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases